Table 1.

Characteristics of total mentees (N = 35) who participated in program

Median (IQR) or n (%)
Age 32 (30-33) 
Sex assigned at birth  
Female 28 (80%) 
Male 7 (20%) 
Gender identity  
Female 28 (80%) 
Male 7 (20%) 
Race/ethnicity  
White 16 (46%) 
Asian 12 (34%) 
Black 2 (6%) 
Arab 1 (3%) 
White and Native American 1 (3%) 
Hispanic 3 (8%) 
Type of medical degree  
MD or MBBS 30 (86%) 
DO 5 (14%) 
Location of medical degree  
United States 25 (71%) 
International medical graduate 10 (29%) 
Type of H/O fellowship  
Adult 12 (34%) 
Pediatric 23 (66%) 
Year of training at time of application  
First-year fellow 10 (28%) 
Second-year fellow 16 (46%) 
Third-year fellow 7 (20%) 
Third-year resident  2 (6%) 
Year of training after start of program   
First-year fellow 2 (6%) 
Second-year fellow 10 (28%) 
Third-year fellow 17 (49%) 
>Third-year fellow 6 (17%) 
Location of current US training program  
West 5 (14%) 
Southwest 2 (6%) 
Midwest 11 (31%) 
Southeast 7 (20%) 
Northeast 10 (29%) 
Previous CH mentorship before program 24 (69%) 
Previous research experience in CH before program  30 (86%) 
Participated in a formal hematology-focused research program before this program§  9 (26%) 
Total publications|| before program 3 (1-6) 
CH publications§ before program 1 (0-2) 
Total poster/oral presentations before program 6 (3-10) 
CH poster/oral presentations before program 2 (1-3) 
Medical education or quality improvement activity related to CH before program 22 (63%) 
Member of a H/O professional society 28 (80%) 
Median (IQR) or n (%)
Age 32 (30-33) 
Sex assigned at birth  
Female 28 (80%) 
Male 7 (20%) 
Gender identity  
Female 28 (80%) 
Male 7 (20%) 
Race/ethnicity  
White 16 (46%) 
Asian 12 (34%) 
Black 2 (6%) 
Arab 1 (3%) 
White and Native American 1 (3%) 
Hispanic 3 (8%) 
Type of medical degree  
MD or MBBS 30 (86%) 
DO 5 (14%) 
Location of medical degree  
United States 25 (71%) 
International medical graduate 10 (29%) 
Type of H/O fellowship  
Adult 12 (34%) 
Pediatric 23 (66%) 
Year of training at time of application  
First-year fellow 10 (28%) 
Second-year fellow 16 (46%) 
Third-year fellow 7 (20%) 
Third-year resident  2 (6%) 
Year of training after start of program   
First-year fellow 2 (6%) 
Second-year fellow 10 (28%) 
Third-year fellow 17 (49%) 
>Third-year fellow 6 (17%) 
Location of current US training program  
West 5 (14%) 
Southwest 2 (6%) 
Midwest 11 (31%) 
Southeast 7 (20%) 
Northeast 10 (29%) 
Previous CH mentorship before program 24 (69%) 
Previous research experience in CH before program  30 (86%) 
Participated in a formal hematology-focused research program before this program§  9 (26%) 
Total publications|| before program 3 (1-6) 
CH publications§ before program 1 (0-2) 
Total poster/oral presentations before program 6 (3-10) 
CH poster/oral presentations before program 2 (1-3) 
Medical education or quality improvement activity related to CH before program 22 (63%) 
Member of a H/O professional society 28 (80%) 

DO, Doctor of Osteopathic Medicine; MBBS, Bachelor of Medicine and Bachelor of Surgery; MD, Doctor of Medicine.

Pediatrics residents.

Obtained from survey distributed 6 months into program (N = 35).

Based on experiences listed as research or as original publication or presentation (excluding case reports) in curriculum vitae.

§

Includes ASH Hematology Opportunities for the Next Generation of Research Scientists (HONORS), HTRS Trainee Workshop, and HTRS Hematology Fellows Consortium.

||

Includes in-preparation, submitted, under review, accepted, and published manuscripts.

Close Modal

or Create an Account

Close Modal
Close Modal